Market Cap 119.74M
Revenue (ttm) 2.82M
Net Income (ttm) -127.50M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,521.28%
Debt to Equity Ratio 0.18
Volume 611,100
Avg Vol 324,622
Day's Range N/A - N/A
Shares Out 56.75M
Stochastic %K 59%
Beta 0.99
Analysts Strong Sell
Price Target $8.57

Company Profile

TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product candidates include TSC-100 and TSC-101 for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT) is in Phase I clinical trial, as...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 399 9500
Address:
830 Winter Street, Waltham, United States
14kmaker
14kmaker Oct. 2 at 10:50 AM
$TCRX Checkpoint Capital L.P. raised its holdings in TScan Therapeutics by 14.9%, now owning 2,017,650 shares valued at approximately $2.78 million, making it the firm's 10th largest investment. Institutional ownership is significant, with 82.83% of TScan Therapeutics shares held by institutions and hedge funds, indicating strong support from large investors. Analysts have mixed outlooks on the stock, with a consensus rating of "Buy" and a price target range from $7.00 to $10.00, suggesting potential upside despite recent market volatility.
1 · Reply
StockScanners
StockScanners Oct. 2 at 12:40 AM
$TCRX keep watch if this holds above 2
0 · Reply
14kmaker
14kmaker Oct. 2 at 12:02 AM
$TCRX Goldman Sachs Group Inc. grew its stake in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) by 6.0% in the quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 170,349 shares of the company’s stock after acquiring an additional 9,676 shares during the quarter.
1 · Reply
14kmaker
14kmaker Oct. 1 at 8:15 PM
$TCRX only the beginning, news is coming soon about trial initiation-$3
0 · Reply
vu_jade
vu_jade Oct. 1 at 7:35 PM
$TCRX should double from here
0 · Reply
_www_larval_com_
_www_larval_com_ Oct. 1 at 6:47 PM
$TCRX just turned -5% lower to 18% (~2Mv) a moment ago, follow for more volatility.
0 · Reply
RenaissanceTrading
RenaissanceTrading Oct. 1 at 6:16 PM
$TCRX 25% win on a quick day trade 🤑
0 · Reply
patb99
patb99 Oct. 1 at 6:06 PM
$TCRX 🧐
0 · Reply
dantes13
dantes13 Oct. 1 at 6:06 PM
$TCRX 🍸❓️🤔🔥🔥🔥🔥🔥💥👀
1 · Reply
DARKP00L
DARKP00L Oct. 1 at 5:34 PM
$TCRX a lot of eyes on this stock! Brace for potential market action!
0 · Reply
Latest News on TCRX
TScan: 2 Major Milestones Of TSC-101 To Carry Tide In 2025

Mar 7, 2025, 11:31 AM EST - 7 months ago

TScan: 2 Major Milestones Of TSC-101 To Carry Tide In 2025


TScan Therapeutics Announces Closing of Upsized Public Offering

Apr 19, 2024, 10:05 AM EDT - 1 year ago

TScan Therapeutics Announces Closing of Upsized Public Offering


14kmaker
14kmaker Oct. 2 at 10:50 AM
$TCRX Checkpoint Capital L.P. raised its holdings in TScan Therapeutics by 14.9%, now owning 2,017,650 shares valued at approximately $2.78 million, making it the firm's 10th largest investment. Institutional ownership is significant, with 82.83% of TScan Therapeutics shares held by institutions and hedge funds, indicating strong support from large investors. Analysts have mixed outlooks on the stock, with a consensus rating of "Buy" and a price target range from $7.00 to $10.00, suggesting potential upside despite recent market volatility.
1 · Reply
StockScanners
StockScanners Oct. 2 at 12:40 AM
$TCRX keep watch if this holds above 2
0 · Reply
14kmaker
14kmaker Oct. 2 at 12:02 AM
$TCRX Goldman Sachs Group Inc. grew its stake in shares of TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) by 6.0% in the quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 170,349 shares of the company’s stock after acquiring an additional 9,676 shares during the quarter.
1 · Reply
14kmaker
14kmaker Oct. 1 at 8:15 PM
$TCRX only the beginning, news is coming soon about trial initiation-$3
0 · Reply
vu_jade
vu_jade Oct. 1 at 7:35 PM
$TCRX should double from here
0 · Reply
_www_larval_com_
_www_larval_com_ Oct. 1 at 6:47 PM
$TCRX just turned -5% lower to 18% (~2Mv) a moment ago, follow for more volatility.
0 · Reply
RenaissanceTrading
RenaissanceTrading Oct. 1 at 6:16 PM
$TCRX 25% win on a quick day trade 🤑
0 · Reply
patb99
patb99 Oct. 1 at 6:06 PM
$TCRX 🧐
0 · Reply
dantes13
dantes13 Oct. 1 at 6:06 PM
$TCRX 🍸❓️🤔🔥🔥🔥🔥🔥💥👀
1 · Reply
DARKP00L
DARKP00L Oct. 1 at 5:34 PM
$TCRX a lot of eyes on this stock! Brace for potential market action!
0 · Reply
kshonstocks
kshonstocks Oct. 1 at 3:34 PM
$TCRX all over scans 200 dma b/o
0 · Reply
RenaissanceTrading
RenaissanceTrading Oct. 1 at 1:57 PM
$TCRX Crossing the 200 sma 🔥
0 · Reply
14kmaker
14kmaker Sep. 29 at 2:26 PM
$TCRX $TCRX I wonder what penny scalping games we will see today. One day left of third quarter when this company stated they would initiate the first dose of the trial. Hmmm…
0 · Reply
vu_jade
vu_jade Sep. 24 at 6:25 PM
$TCRX looking for a nice pop soon
0 · Reply
14kmaker
14kmaker Sep. 24 at 3:33 PM
$TCRX Bull flag today, we move higher tomorrow
0 · Reply
None_
None_ Sep. 19 at 3:24 PM
$TCRX Found this https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176717463
0 · Reply
dcme010711
dcme010711 Sep. 18 at 1:16 AM
0 · Reply
Deliver1
Deliver1 Sep. 17 at 9:12 PM
$TCRX : TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025 https://finance.yahoo.com/news/tscan-therapeutics-announces-upcoming-oral-110000014.html
0 · Reply
Voltaire11
Voltaire11 Sep. 10 at 4:48 PM
$TCRX Pattern holding. Down cycle, great time to buy. Look at chart. It's easy to predict. Within a week it will again approach the $2.00 wall. Nothing guaranteed of course, but, until the pattern breaks.... Regardless, if the pattern does not hold the stock in of itself at these prices is a good play in the longer run.
0 · Reply
Deliver1
Deliver1 Sep. 9 at 3:11 AM
$TCRX : September Company Presentation https://ir.tscan.com/static-files/1d066354-1ed3-4f4f-b97b-28806d9da9f5 Upcoming conferences: Morgan Stanley - Sept.9 Wainwright - Sept.10
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 5 at 3:32 PM
$TCRX Excellent article that nails exactly where TCRX stands right now. So if you want to update your TCRX knowledge or get acquainted with TCRX, this is a must read. https://beyondspx.com/quote/TCRX/tscan-therapeutics-unlocking-t-cell-precision-in-oncology-s-next-frontier-nasdaq-tcrx#analysis
1 · Reply
14kmaker
14kmaker Sep. 5 at 1:48 PM
$TCRX this one is on the move!!!
0 · Reply